BPA Call 75H71221A00014-75H71225F28007
- Roche Diabetes Care Inc. received a $201,132 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Indian Health Service (IHS) on September 23, 2021, for the supply of diabetic testing supplies to the Phoenix Indian Medical Center (PIMC) in Phoenix, Arizona. This contract, which concluded on September 26, 2022, was awarded without a set-aside designation, indicating open competition. The award falls under the General Services Administration's In-vitro Diagnostics, Reagents, and...
- The Department of Health and Human Services Indian Health Service awarded a $250,000 Blanket Purchase Agreement Call contract to Roche Diabetes Care Inc. for Diabetic Testing Supplies for the Phoenix Indian Medical Center. Roche Diabetes Care Inc. will provide these supplies under its Roche Diabetes Care, Inc. Division and through its Master GSA Schedule Contract for In Vitro Diagnostics, Reagents, and Test Kits. The contract has a base period of performance from November 29, 2022 through...
- This federal contract award is for the delivery of diabetic testing supplies to the Indian Health Service (IHS), a civilian agency within the U.S. government. The prime contractor is Roche Diabetes Care Inc., a for-profit manufacturer of medical diagnostic products and diabetes management solutions. The contract has a ceiling value of $29,700.00 and is a firm fixed-price delivery order, with an ultimate completion date of October 31, 2023. The contract is not designated as a set-aside and was...
- This is a delivery order issued against Roche Diabetes Care Inc.'s General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and test kits. The contract, valued at $510,000.00, is with the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services that provides health services to American Indian and Alaska Native populations. The award is for FY 2025 and will provide the IHS with a Blanket Purchase...
- This is a firm-fixed-price delivery order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diabetes Care Inc. for the provision of diabetes supplies. The $1,280,826.00 order is placed against Roche's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and test kits. The contract does not have a set-aside designation. Roche, a leading manufacturer of...
- The Department of Health and Human Services Indian Health Service awarded a $204,000 purchase order to Roche Diabetes Care Inc. for medical supplies under the GIMC BPA ROCHE DIABETES CARE blanket purchase agreement. Roche Diabetes Care, Inc. Division will provide diabetes care products and services to support the Indian Health Service's healthcare programs in Gallup, New Mexico. The firm fixed price contract runs from September 2022 through September 2025. No subcontractors or set aside...
- This contract award to Roche Diabetes Care Inc. for $99,966.00 was issued by the Indian Health Service (IHS), which is part of the U.S. Department of Health and Human Services. The award is a delivery order under Roche's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. This order is for outpatient diabetes supplies such as test strips, meters, and related consumables to support IHS diabetes programs. The contract...
- This is a federal purchase order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diabetes Care Inc. for medical and surgical instruments, equipment, and supplies. The contract has a firm fixed-price and a ceiling value of $618,686.04. It is not designated as a set-aside contract. Roche Diabetes Care Inc. is a leading manufacturer of diabetes management products and services. Through this contract, as well as existing...
- The Department of Health and Human Services Indian Health Service (HHS IHS) awarded a Delivery Order valued at $749,890.32 to Roche Diabetes Care Inc., a manufacturer and supplier of diabetes management products and services. The contract is for the provision of Medical and Surgical Instruments, Equipment, and Supplies, and is under Roche's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. This contract does not...
- This is a delivery order federal contract awarded by the Indian Health Service (IHS), a component of the U.S. Department of Health and Human Services, to Roche Diabetes Care Inc. for medical and surgical instruments, equipment, and supplies. The $619,895.76 firm-fixed-price contract was awarded on December 14, 2016 and has an ultimate completion date of September 30, 2017. The contract was issued against Roche's existing General Services Administration (GSA) Federal Supply Schedule contract...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D50597-75H71221A00014Blanket Purchase Agreement
- 75H71221A00014-75H71225F28007BPA Call
Roche Diabetes Care Inc. received a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $250,000 from the Indian Health Service (IHS) on August 7, 2025, with an ultimate completion date of September 26, 2026. This non-competitive award is performed at the Phoenix Indian Medical Center in Phoenix, Arizona, and falls under the GSA's In-vitro Diagnostics, Reagents, and Test schedule (FSS-65-VII). The contract supports IHS's mission to provide comprehensive diabetes management supplies and services to American Indian and Alaska Native communities through the Phoenix facility. This BPA call represents a child contract under Roche's existing Blanket Purchase Agreement with IHS, which was originally established on September 23, 2021, with a potential value of $2 million and specifically supports the Phoenix Indian Medical Center through September 26, 2026. Roche Diabetes Care Inc., headquartered in Indianapolis, Indiana, is an established manufacturer and federal supplier specializing in diabetes management products, including blood glucose monitors, test strips, lancets, and control solutions. The company has demonstrated consistent performance delivering critical diagnostic testing materials and medical consumables to federal healthcare organizations, with particular expertise in supporting specialized populations within the IHS and Bureau of Prisons healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $250.0k | 8/7/25 |